Current Trials

Screenshot 2025-03-04 at 14.15.47
ASPIRING

  Antiplatelet Secondary Prevention International Randomised study after INtracerebral haemorrhaGe Background: Survivors of stroke due to spontaneous intracerebral haemorrhage (ICH)…

Screen Shot 2022-05-18 at 3.14.34 pm
CASPER

CASPER: Colchicine After Stroke to Prevent Event Recurrence Chief Investigator A: Prof. Anthony Keech, NHMRC Clinical Trial Centre Chief Investigator…

Screenshot 2025-03-04 at 14.08.20
ECHOES-AF

Evaluating Cerebral micro-bleeding cHanges to Optimise anticoagulation thErapy in Stroke patients with Atrial Fibrillation Lead PI: Dr. Zien Zhou No. of…

Screenshot 2025-03-11 at 15.39.34
LOTUS

Low dOse combinaTions to improve stroke oUtcomeS (LOTUS) Lead PIs: Dr Sonali Gnanenthiran, Prof Anthony Rodgers, Prof Timothy Kleinig, A/Prof Seana…

POST-ETERNAL Logo
POST-ETERNAL

Extending the time window for Tenecteplase by Effective RecanalizatioN of bAsilar artery occLusion in patients with POSTerior circulation stroke Lead PI:  Dr Fana Alemseged Participating…

Screen Shot 2023-04-12 at 1.24.16 pm
QASC Australia

QUALITY IN ACUTE STROKE CARE (QASC) AUSTRALIA TRIAL Principal Investigator: Prof Sandy Middleton The Quality in Acute Stroke Care (QASC)…

image003
RESPECT-ETB

Extensive research is being conducted in search of neuroprotective agents for possible use in the acute phase of stroke and…

Screen Shot 2022-05-18 at 3.42.17 pm
STARS

Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS) Study Lead PI: Dr Candice Delcourt Status: Recruiting No. of…

Screenshot 2025-10-17 at 12.04.41
TOSCCAA-TXA

TOSCCAA-TXA: Treatment Of Stroke reCurrence in Cerebral Amyloid Angiopathy with TraneXamic Acid Lead PI: Professor Geoffrey Cloud Status: Recruitment commenced…

UPLIFT LOGO
UPLIFT

A phase IIa multicentre umbrella trial of integrated UPper limb and Language Impairment and Functional Training (UPLIFT). Lead PI: Dr…